EMPALINA Trademark

Trademark Overview

On Tuesday, February 28, 2012, a trademark application was filed for EMPALINA with the United States Patent and Trademark Office. The USPTO has given the EMPALINA trademark a serial number of 79111696. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, March 1, 2022. This trademark is owned by Boehringer Ingelheim International GmbH. The EMPALINA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, for the treatment of diabetes; pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract, metabolism, blood and blood forming organs
empalina

General Information

Serial Number79111696
Word MarkEMPALINA
Filing DateTuesday, February 28, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, March 1, 2022
Registration Number4273939
Registration DateTuesday, January 15, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations, for the treatment of diabetes; pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract, metabolism, blood and blood forming organs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events

Event DateEvent Description
Tuesday, October 4, 2022UNDELIVERABLE MAIL - NO ACTION TAKEN
Monday, September 19, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Monday, September 19, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, July 3, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, June 4, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, June 4, 2020INVALIDATION PROCESSED
Thursday, April 16, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, August 16, 2019CANCELLED SECTION 71
Saturday, April 20, 2013NOTIFICATION PROCESSED BY IB
Wednesday, February 20, 2013FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 20, 2013FINAL DISPOSITION PROCESSED
Thursday, February 14, 2013GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, January 15, 2013REGISTERED-PRINCIPAL REGISTER
Friday, December 7, 2012EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, November 14, 2012CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, November 13, 2012ASSIGNED TO PETITION STAFF
Wednesday, November 7, 2012POST PUBLICATION AMENDMENT RECEIVED
Wednesday, November 7, 2012PAPER RECEIVED
Monday, August 13, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 30, 2012EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 24, 2012PUBLISHED FOR OPPOSITION
Wednesday, July 4, 2012NOTICE OF PUBLICATION
Thursday, June 14, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 8, 2012ASSIGNED TO EXAMINER
Friday, May 11, 2012APPLICATION FILING RECEIPT MAILED
Monday, May 7, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 4, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, May 3, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

empalina blood treatment preparations pharmaceutical organs metabolism forming disorders diabetes diseases